Chikungunya supportive therapy: There was a lack of

There was a lack of high-quality CMGs that provided supportive care and treatment guidance, which may impact patient care and outcomes. It is essential that existing guidelines are updated and adapted to provide detailed evidence-based treatment guidelines for different at-risk populations. There is no specific treatment for chikungunya virus disease ( chikungunya ); clinical management is supportive . Patients suspected to have chikungunya should be managed for dengue until dengue has been ruled out. Some of the most used pharmaceutical therapies for CHIKV include non-steroidal anti-inflammatory drugs (NSAIDS), methotrexate (MTX), chloroquine, and ribavirin. Currently, there is no commercially available vaccine for chikungunya , but vaccine development is crucial for this virus. Learn about Chikungunya during the monsoon season—its symptoms, causes, diagnosis, treatment options, and preventive measures. Understand key risk factors and how to stay protected in high-risk areas.